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FR-008/candicidin is a heptaene macrolide with
established antifungal activity, produced by Strepto-
myces sp. FR-008 as a complex mixture of com-
pounds. Here, six components (FR-008-I to -VI) of
the FR-008/candicidin complex were determined;
III, V, and VI were confirmed as natural products,
principally differing from each other at C-3 and C-9,
while the other three were believed to originate
from the respective conversions of the natural ones
in vitro. Inactivation of KR21 and DH18, respectively,
abolished production of V carrying a C-3 hydroxyl,
and VI carrying a C-9 methylene. Combined inactiva-
tion created a mutant producing only III, with a C-3
ketone and a C-9 hydroxyl, and having antifungal ac-
tivity superior to V and comparable to VI. Incomplete
activities of KR21 and DH18 were, therefore, unam-
biguously identified as being involved in structural
variations of FR-008 complex.
INTRODUCTION
Antifungal polyene macrolides, synthesized mainly by bacteria,
are a large class of natural products consisting of 20 to 44 mem-
bered macrolactone rings with a characteristic series of three to
eight conjugated double bonds, as well as an exocyclic carboxyl
group and an unusual mycosamine sugar (Aparicio et al., 2003).
The academically and therapeutically relevant examples are four
glycosylated polyenes, amphotericin, pimaricin, nystatin, and
FR-008/candicidin, of which the biosynthetic gene clusters
have been sequenced and well analyzed as a class of so-called
type I modular polyketide synthases (PKSs) (Aparicio et al., 2000;
Brautaset et al., 2000; Caffrey et al., 2001; Campelo and Gil,
2002; Chen et al., 2003).
Aside from being well known as effective clinical antifungal
agents, some glycosylated polyenes also inhibit HIV replication,
hamper the development of prion-related diseases, and can
even be useful in cancer therapies (Zotchev, 2003). Mechanisti-
cally, polyenemacrolides generally interact with ergosterol in the
fungal cell membrane, causing leakage of small molecules and
ions, and resulting in cell death (Bolard, 1986). However, theirChemistry & Biologyaffinity for cholesterol in the mammalian cell membrane causes
polyene macrolides to have serious side effects (Zotchev,
2003). Moreover, water insolubility general displayed by polyene
macrolides also limits their clinical application. There is, thus, an
urgent need to develop novel polyene derivatives with improved
pharmacological properties, or with reduced side effects.
Type I polyketide biosynthesis is catalyzed by modular PKSs
that usually consist of giant multifunctional proteins with discrete
catalytic domains responsible for each successive cycle in chain
building and modification (Hopwood and Sherman, 1990; Katz
and Donadio, 1993). Each set, or module, of domains is respon-
sible for one cycle of polyketide chain elongation, and minimally
consists of three functional domains: ketosynthase (KS), acyl-
transferase (AT), and acyl carrier protein (ACP). Besides, PKS
module may optionally contain modifying domains (i.e., a ketore-
ductase [KR], a dehydratase [DH], and/or an enoyl reductase
[ER]). The KR reduces the b-ketothioester intermediate gener-
ated by the KS to a b-hydroxythioester, and the DH dehydrates
the resulting intermediate into an a,b-unsaturated ester, while
the ER hydrogenates the olefin to yield a fully reduced b-carbon
atom (Schwecke et al., 1995). Post-PKS steps, such as sugar at-
tachment, hydroxylation, and methylation, further diversify the
structures of the end-products.
The complexities of PKS pathways result in their metabolites
usually being produced as a series of structurally related compo-
nents by variation of either the PKS or post-PKS steps. Many
structurally related derivatives of polyketides have been attrib-
uted to variations during chain assembly, including the genera-
tion of keto, hydroxyl, enoyl, or methylene groups in the carbon
chain by variations in KR, DH, and ER activity. Substrate flexibil-
ity of the AT in the loading domain creates a series of avermectin
derivatives, and epothilones A and B were presumed to be co-
produced by the relaxed specificity of AT4 accepting either ma-
lonyl or methylmalonyl extender units (Ikeda et al., 1999; Mars-
den et al., 1998; Tang et al., 2000). Pikromycin macrolactones
were coproduced as 12 and 14 membered rings by ‘‘skipping’’
of the final condensation cycle (Xue and Sherman, 2000). Incom-
plete DH2 activity in avermectin biosynthesis resulted in two
groups of compounds containing a hydroxyl group or enoyl car-
bons at C22-23 (Ikeda et al., 1999). Sluggish ER5 in AmphC
should account for the coexistence of amphotericins A and B
(Caffrey et al., 2001), and failed enoyl reduction (ER5) was pro-
posed to give several heptaene nystatin derivatives (Bruheim
et al., 2004). Post-PKS variations include the production of15, 629–638, June 2008 ª2008 Elsevier Ltd All rights reserved 629
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ation by EryK (Stassi et al., 1998), and nystatin A1, A3, and
NYST1070 are generated by different sugar moiety attachment
(Bruheim et al., 2004).
Manipulation of such variation can be exploited to produce
more useful products or reduce undesired byproduct levels.
The production of a desired avermectin derivative (CHC-B2)
was improved by engineering the aveC gene to improve the effi-
cacy of DH2 in AVES1 (Stutzman-Engwall et al., 2005). Mutagen-
esis of eryF and eryK, respectively encoding C-6 and C-12 hy-
droxylations in erythromycin, accelerated the accumulation of
6,12-dideoxyerythromycin A (Stassi et al., 1998).
FR-008/candicidin, a heptaene macrolide with antifungal ac-
tivity, is produced by Streptomyces sp. FR-008. Bioinformatic
and mutational analysis of the completely sequenced FR-008
gene cluster revealed FR-008 to be synthesized by a typical
type I PKS pathway composed of 21 elongation steps and two
late modifications (i.e., carboxylation and mycosamine attach-
ment) (Chen et al., 2003; Hu et al., 1994). Four structurally related
compounds, FR-008-I to -IV (named FR-008 series to distinguish
them from the identical compounds, candicidin A to D, produced
by Streptomyces griseus IMRU3570; Campelo and Gil, 2002;
Zielinski et al., 1979), were believed to constitute the FR-008
mixture, of which FR-008-II was confirmed by NMR and consid-
ered as an isomer of FR-008-III due to equivalence of hemiketal
moiety formation between C-15 and C-19 on the FR-008 agly-
cone in vitro (Chen et al., 2003).
Here we describe improved LC-MS analysis of FR-008 com-
plex and NMR characterization of three main FR-008 compo-
nents. Initially, six components (FR-008-I to -VI), instead of four
previously detected from Streptomyces sp. FR-008 and S. gri-
seus IMRU3570, were examined for their exact chemical struc-
tures. FR-008-V, -III, and -VI, were compared with previously re-
ported FR-008-I, -II, and -IV, respectively, of which the isomeric
relationship of II and III was further confirmed by NMR analysis in
our work. Combined with the structural information, further
point-mutation experiments proved that the coproduction of
the three FR-008 compounds (FR-008-III, -V, and -VI) was prin-
cipally induced by incomplete activities of KR21 and DH18 dur-
ing polyketide chain elongation. Notably, double mutagenesis of
KR21 andDH18 created a novel strain, producing only FR-008-III
with an antifungal activity superior to that of FR-008-V and com-
parable to that of FR-008-VI. The results establish that domain
modification (e.g., DH, KR, or ER) in a PKS can be manipulated
effectively to generate structural variations and/or for rational
accumulation of a pure metabolite with superior activity.
RESULTS
Structural Elucidation of FR-008 Compounds
The FR-008 complex was reported to consist of four main com-
ponents, FR-008-I, -II, -III, and -IV, in vivo, of which FR-008-II
was confirmed by NMR and assumed to be an isomer of FR-
008-III due to equilibrium of hemiketal moiety formation between
C-15 and C-19 on the FR-008 aglycone (Chen et al., 2003).
A reexamination of the FR-008 extract from liquid fermentation
broth by improved LC/ESI-MS analysis, however, indicated
coexistence of six components instead of four (Figure 1A).
They can be grouped as three pairs of isomers (instead of one)630 Chemistry & Biology 15, 629–638, June 2008 ª2008 Elsevier Ltby their identical MS spectra (i.e., the pairs FR-008-I and
-V [(M  H) = 1110.6; (M + H)+ = 1112.1], FR-008-II and -III
[(M  H) = 1108.8; (M + H)+ = 1110.0], and FR-008-IV and -VI
[(M  H) = 1092.9; (M + H)+ = 1094.0]. In freshly made extracts
of mycelia from liquid fermentation or spores from solid fermen-
tation, in contrast, only FR-008-V, -III, and -VI could be detected,
and their isomers (FR-008-I, -II, and -IV) only appeared later, after
the samples were kept at room temperature for 1 or more days
(Figure 1B), implying that only FR-008-III, -V, and -VI are authen-
tic natural products of FR-008 biosynthesis.
FR-008-III, -V, and -VI were purified by preparative reverse-
phase HPLC and subjected to LC/ESI-MS and NMR (600 MHz,
DMSO-d6) analyses. Their structures were determined by 1D
and 2D-NMR spectroscopy, including double quantum filter cor-
related spectroscopy (DQF-COSY), total correlated spectros-
copy (TOCSY), nuclear Overhauser enhancement spectroscopy,
heteronuclear multiple quantum coherence and heteronuclear
multiple bond correlation. According to NMR data, FR-008-III
was confirmed as being identical to candicidin D (Zielinski
et al., 1979). In contrast to the documented FR-008-II (Chen
et al., 2003), FR-008-III, -V, and -VI all have a hemiketal moiety
between C-15 and C-19 with the quaternary carbon signals
located between d96.4 and d97.4 on their 13C-NMR spectra
(see the Supplemental Data available online).
The difference between FR-008-V and -III is only at C-3, where
a hydroxyl group present in the former is replaced by a keto-
group in the latter (Figure 1B). Comparison of 13C-NMR and
1H-NMR data of FR-008-V with those of FR-008-III revealed
lack of carbonyl signal (d202.1) and appearance of an additional
proton signal at d3.75 corresponding toC-3position in FR-008-V.
Thepresenceof a hydroxyl groupatpositionC-3 inFR-008-Vwas
also confirmed by the 2D-NMR spectra, in which the proton
signal at d3.75 showed correlation with a pair of germinal protons
H-2 and a coupling network fromH-4 toH-6 (see the Supplemen-
tal Data).
The structure of FR-008-VI differed from that of FR-008-III in
the partial structure between C-3 and C-13, where the hydroxyl
groups at C-9 and C-13 were absent, and an additional hy-
droxyl group was present at C-5 in FR-008-VI (Figure 1B). Com-
parison of DQF-COSY and TOCSY spectra between FR-008-VI
and FR-008-III reveals that the proton signals corresponding to
H-9 and H-13 of FR-008-III disappeared in FR-008-VI; instead,
a novel proton signal at d4.26 appeared in FR-008-VI, and
shows correlations with two pairs of germinal proton signals
at d2.38/d2.58 and d2.28/d2.33. These are all a-protons of car-
bonyl groups and are therefore assigned as H-5, H-4, and H-6,
respectively. The structure of segment C-1 to C-6 of FR-008-VI
could be confirmed by the evidence of JCH long-range hetero-
nuclear coupling correlation in the HMBC spectrum (see the
Supplemental Data).
fscO Is Not Responsible for C-9 Hydroxyl Restoration
fscO, showing 34% similarity and 25% identity to an FAD-
dependent monooxygenase from Agrobacterium tumefaciens
C58, lies at the left end of the FR-008 gene cluster, and was ini-
tially assumed to restore the C-9 hydroxyl group by a tailoring
modification (Chen et al., 2003). To assess the role of fscO in
FR-008 biosynthesis, a 527 bp DNA fragment internal to fscO
(1380 bp) was replaced by a cassette carrying the apramycind All rights reserved
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ysis revealed no detectable structural changes in fermentation
extracts of the resultant mutant ZYJ-1 compared with that of
the parental strain, and, therefore, fscO has no involvement in
C-9 hydroxylation on FR-008 aglycone (data not shown).
Inactivation of KR21 Abolished FR-008-V Production
Structural elucidation revealed that FR-008-V and -III differed
only at C-3, where a hydroxyl group in the former is replaced
by a keto group in the latter (Figure 1B). According to the elonga-
tion steps of FR-008 polyketide, KR21 in FscF could reduce
Figure 1. LC-MS Profile and Structural
Variations of Six FR-008 Components
(A) LC-MS analysis of the FR-008 sample ex-
tracted from liquid fermentation broth, or from
the sample stored 1 day at room temperature after
being extracted from spores or mycelia. The six
components (FR-008-I to -VI) can be grouped as
three pairs by identical molecular weight (MW):
FR-008-I and -V (MW, 1111); FR-008-II and -III
(MW, 1109); and FR-008-IV and -VI (MW, 1093).
(B) Structural variations of FR-008 components.
Coexistence of ketone or hydroxyl at C-3 and
also methylene or hydroxyl at C-9 in FR-008 agly-
cones was genetically identified as resulting from
respective incomplete activities of KR21 and
DH18 during polyketide biosynthesis (Figure 3).
The vertical boxes highlight the hemiketal ring be-
tween C-15 and C-19 in the aglycones of FR-008-
V, -III, and -VI. They also highlight the opening of
the hemiketal ring in the aglycones of FR-008-I,
-II, and –IV, which were respectively formed by in
vitro conversions of the three former structures
at room temperature. The unexpected groups at
C-5 and C-13 in FR-008-VI are inconsistent with
the structure predicted from domains 16 and 20
(Figure 2), and are assumed to be generated
from disorder biosynthesis.
the b-ketothioester intermediate into the
b-hydroxythioester at C-3, and, thus,
should be necessary for producing FR-
008-V (Figure 2). We thus set out to
inactivate KR21 by generating a point
mutation.
A putative catalytic triad consisting of Y
(Tyr), S (Ser), and K (Lys) residues, con-
served in short-chain dehydrogenases/
reductases (Reid et al., 2003), was iden-
tified in KR21 based on alignment of
active-site sequences of grouped KR do-
mains from FR-008 (Figure 3A). To inacti-
vate KR21 in FscF, the active residue
Y1526 was replaced by F (Phe), with an
additional restriction site (ApoI) intro-
duced to facilitate the screening of mu-
tants (Figure 4A). Three identical mutants
of KR21 were confirmed by PCR amplifi-
cation, ApoI digestion, and sequencing
of the PCR products. Clearly, no FR-
008-V was found to be accumulated in KR21 mutant (ZYJ-2),
whereas FR-008-III and -VI were normally produced, as shown
by HPLC analysis (Figure 4B). Therefore, the activity of KR21
was identified to be essential for the generation of FR-008-V
bearing a C-3 hydroxyl. The total yield of FR-008/candicidin
antibiotics in ZYJ-2 was approximately 60% of that from the
wild-type.
Inactivation of DH18 Abolished FR-008-VI Production
DH18 and ER18 should be responsible for dehydration and
enoyl reduction during the 18th elongation step, to produceChemistry & Biology 15, 629–638, June 2008 ª2008 Elsevier Ltd All rights reserved 631
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KR21 and DH18 are marked by black circles. Dashed circles represent the silent domains. KR21 (ketoreductase) is expected to reduce C-3 b-keto into a b-hy-
droxyl group at the last elongation step, and DH18 (dehydratase) and ER18 (enoyl reductase) are expected to be responsible for eliminating the C-9 b-hydroxyl to
generate C-9 methylene during the 18th elongation. Mutagenesis analysis of KR21 and DH18 indicated: V and III (FR-008-V and -III) were produced under the
DH18 silence; III and VI (FR-008-III and -VI) were produced under the KR21 silence; and III (FR-008-III) was generated by the synchronous silences of KR21 and
DH18 (Figure 4).the C-9 methylene in the FR-008 aglycone (Figure 2). Structural
characterization proved that the C-9methylene is only present in
FR-008-VI, whereas both FR-008-V and -III carry a C-9 hydroxyl
instead. This implies that DH18 could have been active when
forming component VI but nonfunctional when producing FR-
008-V and FR-008-III (Figure 2). Keeping in mind that the activity
of DH18 should be unnecessary for FR-008-V and -III produc-
tion, we set out to inactivate DH18 by the means of a point
mutation.
Almost all hitherto-identified DH domains from modular PKSs
have the active-site motif H(X3)G(X4)P, such as the consensus
sequence of DH domains in the biosynthesis of avermectin, am-
photericin, rifamycin, nystatin, and nanchangmycin (Brautaset
et al., 2000; Caffrey et al., 2001; Ikeda et al., 1999; Sun et al.,
2003; Tang et al., 1998). The same active-site motif was found
in the DHs of FR-008 (Figure 3B). The His (H) residue in the motif
was suggested to be essential for catalytic activity of DH do-
mains, since there aremany cases of inactive DHswith inartificial
mutation(s) at the site, such as DH17 of AmphJ and DH6 of
NanA4, each with the mutation of H (His) to R (Arg) (Caffrey
et al., 2001; Sun et al., 2003), and DH17 of NysJ and DH7 of
AVES3, each with the mutation of H (His) to Y (Tyr) (Ikeda
et al., 1999; Sun et al., 2003).
To inactivate DH18, the amino acid replacement, H3084Y in
FscE, was introduced into the active site of DH18. For introduc-
ing an additional restriction site (BsrGI), D (Asp) 3083 in FscEwas
replaced by V (Val) simultaneously (Figure 4A) . Three identical
DH18 mutants (ZYJ-3) were selected on the basis of the intro-632 Chemistry & Biology 15, 629–638, June 2008 ª2008 Elsevier Ltdduction of the additional BsrGI restriction site into the DH18
coding region.
As expected, FR-008-VI disappeared, while FR-008-V and -III
accumulated normally in the fermentation extract of ZYJ-3 ac-
cording to HPLC analysis (Figure 4B). DH18 is therefore con-
firmed to be necessary for generation of FR-008-VI by removing
the C-9 hydroxyl in the FR-008 aglycone. The polyene yield of
ZYJ-3 reached approximately the same level as that of the
wild-type strain. Interestingly, two apparently novel components,
FR-008-New-1 and -2 (Figure 4B), could be detected at relatively
low levels in ZYJ-3. They were purified by preparative HPLC and
subjected to LC/ESI-MS analysis, andwere proven to be FR-008
analogs with typical heptaene absorption spectra, and the mass
spectra, m/z 1108.7 [M  H] (FR-008-New-1) and m/z 1092.6
[M  H] (FR-008-New-2), respectively (data not show).
Only FR-008-III Preserved in KR21
and DH18 Double Mutant
Double mutant ZYJ-6 was obtained by introducing a further
DH18 mutation (H3084Y and D3083V) into a pregenerated
KR21 mutant, ZYJ-2, by the same way as ZYJ-3 generation in
the wild-type strain (Figure 4A). The components bearing a C-3
hydroxyl (FR-008-V) or a C-9 methylene (FR-008-VI) were de-
stroyed, and only FR-008-III produced under the nonfunctional
DH18 and KR21 was preserved in the resultant mutant ZYJ-6
(Figure 4B). The polyene yield in ZYJ-6 was approximately
80% of the wild-type level. Interestingly, FR-008-New-1 and -2
were also accumulated in ZYJ-6 (Figure 4B).All rights reserved
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Only the regions containing proposed active sites are shown. The proposed catalytic residues are marked with asterisks. (A) KR domains and (B) DH domains
(KR21 and DH18 discussed in this work are boxed). Solid bars represent the conserved motifs, GXG(X2)G(X3)A as NADP(H) binding motif in KRs; H(X3)G(X4)P as
active-site motif in DHs.Comparison of the Antifungal Activities
of FR-008-V, -III, and -VI
A series of 2-fold antibiotic dilutions were tested for growth inhi-
bition of the test organism, S. cerevisiae Y029 (see the Experi-
mental Procedures). GI50 values (50% of isolates inhibited)
were estimated from the inhibition curve of each polyene. The
antifungal activity of FR-008-III (0.90 mg/ml) was about twice
that of FR-008-V (2.0 mg/ml), and comparable to that of FR-
008-VI (0.75 mg/ml).
DISCUSSION
While the FR-008/candicidin complex produced from either
S. griesus IMRU3570 or Streptomyces sp. FR-008 was previ-
ously reported to be biosynthesized as a mixture of four deriva-
tives (i.e., candicidin A, B, C, and D, or FR-008-I, -II, -III, and -IV
[Chen et al., 2003; Zielinski et al., 1979]), our recent analysisChemistry & Biologyusing improved LC-MS actually detected six FR-008 compo-
nents (FR-008-I to VI) coexisting in the fermentation broth ex-
tract (Figure 1A), which can be grouped as two additional pairs
of isomers by their identical MS spectra (i.e., FR-008-I and -V,
and -IV and -VI, apart from the previously assumed isomeric
pair of FR-008-II and III [Chen et al., 2003]). The structure char-
acterization of FR-008-II and -III supports the interpretation of
FR-008-III being an isomer of FR-008-II, due to hemiketal moiety
formation between C-15 and C-19, and two other pairs of com-
ponents (i.e., FR-008-I and -V, and -IV and -VI) may have derived
in a similar way. Further work indicated that only FR-008-V, -III,
and -VI were present in the fresh sample extracted from cells,
and the counterpart isomers FR-008-I, -II, and -IV were pro-
duced in vitro during the prolonged storage (Figure 1B). The
hemiketal ring, therefore, should have been formed between
the hydroxyl of C-19 and the keto of C-15 in FR-008 precursor
before release, and FR-008-III, -V, and -VI should only be15, 629–638, June 2008 ª2008 Elsevier Ltd All rights reserved 633
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(A) Mutation sites in DH18 and KR21 domains, and the relationship between the wild-type (FR-008) and its mutants (ZYJ-2, -3, and -6). Asterisks represent the
mutated domains. The mutation in KR21 is Y1526F with an additional restriction site (ApoI) introduced. The mutation in DH18 is H3084Y with an additional mu-
tation, D3083V, generated for introducing a restriction site (BsrGI).
(B) HPLC analysis (detection at 380 nm) of the fermentation culture extracts of ZYJ-2, -3, and -6 compared with wild-type. Threemajor FR-008 components (V, III,
and VI) were detected in the wild-type, while component Vwas absent in ZYJ-2; ZYJ-3 lost production of VI; and the double mutant (ZYJ-6) produced only III. Two
novel components (FR-008-New-1 and -2) detected in ZYJ-3 and -6 are marked as New-1 and New-2, respectively.regarded as the authentic natural products that resulted from
FR-008 biosynthesis.
Indeed, the retention of the C-3 keto group in FR-008-III and
-VI, and of the C-9 hydroxyl in FR-008-III and -V (Figure 1B),
would disagree with the characterized biosynthetic pathway
mostly based on bioinformatic alignments if KR21 (which re-
duces the b-keto into a b-hydroxyl group at C-3 of the FR-008
aglycone during the final elongation step) and DH18-ER18
(which reduces the b-carbon atom during the 18th elongation
step at the C-9 position) could exert their full activities (Figure 2).
Our knockout experiments targeting the specific residues of
DH18 and KR21 supported the hypothesis that they could not
fully execute their activities during polyketide elongation. Fur-
thermore, in view of the capacity of some reported P450 mono-
oxygenases to introduce a hydroxyl group at the polyol region of634 Chemistry & Biology 15, 629–638, June 2008 ª2008 Elsevier Ltdpolyene aglycone during the tailoring modification step (Byrne
et al., 2003; Volokhan et al., 2006), the possibility that some un-
identified tailoring modification(s) existed for C-9 hydroxylation
in FR-008 aglycone could not be ruled out completely. It is worth
mentioning, however, that neither fscO (FAD-dependent mono-
oxygenase) nor fscP (P450 monooxygenase gene) from the
FR-008 gene cluster would be responsible for the restoration
of the C-9 hydroxyl based on knockout experiments (S. Chen
et al., unpublished data about fscP).
KR21 and DH18 seem to be only about 21% and 23% active,
respectively, as a result of an estimated production ratio
(2.6:1.0:1.1 for FR-008-III:-V:-VI) derived from by HPLC analysis.
The generated KR21 and DH18 double mutant could have re-
sulted in a complete silencing of the KR21 and DH18 activity,
as FR-008-III was principally accumulated, although at onlyAll rights reserved
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wild-type producer.
The sluggish activity of KR21 should not attribute to its ineffi-
cient utilization of NADP(H), since there are no abnormal alter-
ations found in the NADP(H) binding motif (Aparicio et al.,
1996; Scrutton et al., 1990; Tang et al., 1998) of KR21 (Figure 3A).
The seemingly constant production ratio of the FR-008 series of
compounds, while adjusting NADP(H) supplies by changing
glucose concentrations in the fermentation medium, also
agrees with this assumption (data not shown). This is especially
so, when one considers that NADPH is produced in bacteria
mainly through the pentose phosphate pathway (Borgos et al.,
2006).
A seemingly redundant residue (G3089 in FscE) in the DH18
active-site motif H(X3)GG(X4)P compared to the normal
H(X3)G(X4)P in DHs could not be argued, at present, as a cause
for incomplete activity of DH18. This is because the DH3 in am-
photericin biosynthesis carrying the mismatched active-site mo-
tif (H(X3)A(X4)P) (Caffrey et al., 2001) functions well, and the DH2
in AVES1 was unable to restore the full activity by the normal
substitution of the mismatched active-site motif (H(X3)G(X4)S)
(Ikeda et al., 1999). We have not tried to investigate this question
by replacing the native active-site motif with the normal one.
Similar to the unexplained incomplete activity of KR21, many
intact DH domains were unreasonably silent in PKSs with intact
conserved consensus sequence, such as DH17 and DH21 in FR-
008, DH15 in AmphJ, DH18 in NysK, and DH6 and DH7 in the
rifamycin PKS (Brautaset et al., 2000; Caffrey et al., 2001;
Chen et al., 2003; Tang et al., 1998). It can reasonably be stated
that, except for the active-site motif, the activities of catalytic do-
mains in multifunctional PKS proteins may also be affected by
the interdomain sequences, and even by overall protein confor-
mations, such as the sluggish activity of ER5 in AmphC pre-
sumed to be attributable to a shortened interdomain preceding
ER5, which may restrict movement of the ER5 (Caffrey et al.,
2001). Many engineered hybrid PKS proteins cannot reach ideal
catalytic efficiencies, likely because of the disturbance to native
PKS protein conformations (Kim et al., 2004; McDaniel et al.,
1997; Menzella et al., 2005). One plausible explanation for in-
complete action of KR21 may be that the TE domain (Gokhale
et al., 1999) at the C terminus of FscF could not sufficiently dis-
tinguish between the oxidized form of the polyketide and the
form reduced by KR21 prior to cyclization and release (Chen
et al., 2003). The incomplete action of DH18 may reflect the pre-
mature transfer of the chain from ACP18 to KS19 before DH18
could complete its function.
An unexpected absence of a hydroxyl at C-13 and its unex-
pected presence at C-5 in FR-008-VI (Figure 1B) is somewhat
confusing, as the positional swapping of this hydroxyl group is
totally unexpected from the detected structures of FR-008-V
and -III well consistent with the deduced biosynthesis pathway,
in which the C-13 hydroxyl group should be preserved because
module 16 lacks DH-ER domains, and the C-5 methylene should
be logically generated by the presence of functional DH20-ER20
(Figure 2). The generation of FR-008-VI may represented an
‘‘out-of-order’’ catalysis related to a certain conformation of
FscE, in which the DH18-ER18 may not only act to reduce the
C-9 hydroxyl group specifically, but also exert its duty to the
C-13 hydroxyl group derived from upstream 16th elongation,Chemistry & Biologand thus gave fully reduced C-9 and C-13 atoms, while the silent
DH20 in the case permitted reservation of C-5 hydroxyl. Off-
loaded from FscE, the FR-008-VI precursor processed in FscF
may not be the proper substrate of KR21 for b-ketone reduction
at C-3 position, and thus the FR-008-VI aglycone was produced.
Obviously, the hypothesis needs to be supported experimentally
(e.g., by generating further mutations and/or PKS protein struc-
ture elucidations). Noticeably, another likely atypical PKS was
also found in epothilones biosynthesis, in which the lack of dehy-
dratase domain in module 4 disagrees with the double bond
formation at C12-13 in epothilones structure (Tang et al., 2000).
Trace amounts of two FR-008 compounds (FR-008-New-1
and -2) appeared in the fermentation extract of the DH18 mu-
tants (ZYJ-3 and ZYJ-6) (Figure 4B). Obviously, the generation
of these compounds depends on DH18 mutation, which may
have influenced or altered the activities or specificities of other
catalytic domains in FscE.
Clearly, elucidating the factors controlling metabolite distribu-
tions so as to accumulate more desirable components by ratio-
nal manipulation of the biosynthetic pathways would be of great
value for drug discovery and/or strain improvement. Thus, there
is evident value in our present work, which is based on the de-
tailed elucidation of the molecular structures of three major
FR-008 components (FR-008-III, -V, and -VI), genetically copro-
duced largely as a result of incomplete activities of KR21 and
DH18. In addition, the use of the information for the creation of
a mutant strain producing only one of the superior antifungal
components (FR-008-III) at considerable yield is an additional
example of the potential of metabolic engineering employing
antibiotic producers.
SIGNIFICANCE
Glycosylated polyenes represent a major and very complex
class of antifungal agents, within which candicidin appeared
as the earliest model complex of this family. Considerable
progress had been made in research into this complex, but
little has yet been elucidated about the mechanisms, espe-
cially the genetic controls, of their structural variations.
Our efforts for the detailed characterization of the candicidin
complex compounds not only enabled us to distinguish the
compounds resulting from in vivo conversions, but also
the in vitro process, leading to the studies on the intrinsic
mechanismof the in vivo conversions. This openedawindow
for the creation of more structural variations, or generation
of strains with predominant production of a unique desirable
compound by the rational manipulation of a specific domain
or a combination of specific domains. This may help in the
creation of polyene derivatives with improved pharmacol-
ogical properties, increased activity, reduced toxicity, or
improved water solubility.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, Culture Techniques,
and General Techniques
Streptomyces sp. FR-008 (Chen et al., 2003), the wild-type producer of antibi-
otic FR-008, was used for antibiotic isolation and generation of mutant strains
by targeted gene disruption and replacement. The bioassay organism was
S. cerevisiae Y029, grown in YEME medium at 30C. DH5a (F, recA, lacZ,y 15, 629–638, June 2008 ª2008 Elsevier Ltd All rights reserved 635
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et al., 2002) (an E. coli and Streptomyces shuttle vector) was used for gene re-
placement. pBluescript II SK(+) (Short et al., 1988), pIJ2925 (Janssen andBibb,
1993) and PMD 18-T vector (TaKaRa) were used for clone construction or DNA
sequencing. SFM medium (2% agar, 2% mannitol, 2% soybean powder [pH
7.27.5]) was used for sporulation (30C, 3 days), solid fermentation (30C,
6 days), and conjugation. YEME medium was used for liquid fermentation
(30C, 2 days), and TSBYmedium (10.3% sucrose) was used for growth of my-
celium and isolation of total DNA. LBmediumwas used for E. coli propagation.
Recombinant DNA techniques were described by Sambrook et al. (1989). PCR
reactions were performed with KOD-Plus (TOYOBO).
Bioassay
The concentrations of antibiotics were calculated by measuring the area of UV
peaks at 380 nm in HPLC analysis. Series of 2-fold antibiotic dilutions in DMSO
were prepared for determining the concentrations yielded from complete
growth inhibition to no growth inhibition of the test organism. Test organism
cultures mixed with antibiotic dilutions were incubated at 30C with shaking
at 220 rpm for 8 hr. The optical density measured at 540 nm was plotted
against the antibiotic concentrations to produce a standard inhibition curve.
GI50 (50% of isolates inhibited) was estimated from the repression curve and
used for comparing the activities of each polyene.
Polyene Extraction and Preparative Purification
Wild-type and mutants of Streptomyces sp. FR-008 were grown on SFM at
30C for 8 days. Solid fermentation cultures were extracted with 2 volumes
of methanol three times. The extract solvent was filtrated and concentrated
by evaporation, and then adjusted to 20% methanol solvent, and applied to
a column of C-18 ODS (Kromasil). After washing the column with 2 volumes
of 20% and 40% methanol, in turn, the active fraction was eluted with 100%
methanol, and subsequently evaporated to dryness. The sample was then dis-
solved in a small amount of DMSO ready for subjecting to preparative reverse-
phaseHPLC (Shimadzu) on a ShimadzuC18 203 250mmcolumn at a flow rate
of 8 ml/min. The mobile phase was 45% acetone in 5.5 mmol ammonium ac-
etate (pH 4.5). Each compound was purified by preparative HPLC twice. The
relevant collected fractions were quickly evaporated to aqueous residues at
45C in darkness, and then adjusted to 10% acetone solvent for application
to a 5 cm LC-C18 column (Merck) for sample enrichment and removal of
salt. After washing with 10%methanol, the final sample was eluted with a small
volume of 100% methanol and then dried to a yellow powder under freezing
vacuum. The purity of each sample was above 95%, as assessed by LC-MS
analysis.
LC-MS Analysis of Polyene Samples
Polyene samples were extracted with methanol from spores harvested after 6
day cultivation on soybean agar. LC-MS was operated with the Agilent 1100
series LC/MSD Trap system. The LC column was an Agilent Eclipse XDB-
C18, with dimensions 4.6 3 250 mm run at a flow rate of 0.6 ml min1, and
the mobile phase was 45% CH3CN in 5.5 mmol ammonium acetate (pH 4.5).
The ion trap mass spectrometer was operated with the electrospray ionization
source in the negative or positive ion mode. Drying gas flow was 10 l/min, and
nebulizer pressure was 50 psi. Drying gas temperature was 350C. The frag-
mentation amplitude was varied between 1.0 and 1.8 V.
NMR Experiments
The sample of FR-008 components was dissolved in 500 ml of DMSO-d6, and
TMS was used as internal reference. All NMR experiments were carried out at
600MHz and 25Con aUnity Inova600 Spectrometer. Two-dimensional spec-
tra, such as DQF-COSY (Derome and Willamson, 1990), TOCSY (Bax and Da-
vis, 1985), and rotating frame nuclear Overhauser effect spectroscopy (Jeener
et al., 1979) were performed in phase-sensitive mode by a time-proportional
phase incrementation method. 2D-1H-NMR spectra were recorded with
2,000 (4,000 for DQF-COSY) data points in the t2 dimension, and 512 points
in the t1 dimension in the hypercomplex mode. Raw data were weighted
with a phase-shifted, squared sine bell window function, zero-filled and Four-
ier-transformed to obtain a final matrix of 4,000 3 4,000 data points. The
TOCSY spectra were acquired with the MLEV-17 pulse, with a mixing time636 Chemistry & Biology 15, 629–638, June 2008 ª2008 Elsevier Ltdof 80 ms. The ROESY spectra were measured with a mixing time of 400 ms.
Chemical shifts were calibrated with TMS.
Knockout fscO Gene
A 9.0-kb BamHI fragment isolated from pHZ145 (Hu et al., 1994) was cloned
into the BamHI site of pBluescript Sk+ to give pJTU553, which embodies
two fragments (2.7 kb NotI-KpnI and 2.5 kb SmaI-BamHI) localized beside
the region, nt 1188–660 bp downstream of the start codon of fscO (1380 bp).
One cassette (1.4 kb EcoRI-SmaI fragment) carrying the apramycin resistance
gene, acc(3)IV, was sandwiched between the two fragments recovered from
pJTU553 on the vector pIJ2925, to give pJTU559. The 6.6 kb recombinant
fragment with the internal acc(3)IV gene was BamHI-digested from pJTU559
for ligation into the BamHI site of pHZ1358 to generate a final construction
of pJTU563, which was transferred by conjugation from E. coli ET12567
carrying the RP4 derivative pUZ8002 (Mazodier et al., 1989) into Streptomyces
sp. FR-008. Thiostrepton-sensitive and apramycin-resistant (ThioS-AprR)
colonies were counterselected from the initial ThioR-AprR exconjugants
after two rounds of nonselective growth. Three selected ThioS-AprR exconju-
gants were identified as desired mutants by PCR with primers fscOL 50-
TTGTTCTGCTCCTGCCACCA-30 (sense) and fscOR 50-AACGCTTCGA
CCTGGTCATA-30 (antisense). The 1650 bp PCR product was amplified from
the mutant compared with a 732 bp PCR product from the wild-type. Se-
quencing the 1650 bp PCR product gave further confirmation of the resultant
mutant ZYJ-1.
Point Mutation of KR21: ZYJ-2
For introducing the mutation Y1526F into the active motif of the KR21 domain
(Figure 4A) by targeted gene replacement, the following two pairs of primers
were used: P1, 50-CCGCCTCACCCAACTGCC-30 (sense) and P3, 50-GCGACG
AAATTTGCCTGGCCG-30 (antisense); P4, 50-CCA GGCAAATTTCGTCGC
CGC-30 (sense) and P2, 50-GGGGAG CCGCTGTCGTAGA-30(antisense) (the
introduced restriction site [ApoI] is underlined; P1 and P3 were used for ampli-
fying 528 bp; P4 and P2 were used for amplifying 618 bp). The two PCR frag-
ments with 18 bp end-to-end overlapping were then used as template for
amplifying a 1146 bp fragment with the primers P1 and P2. The 1146 bp
PCR product was digested into one 849 bp SacI-SfiI fragment, and used for
replacing the corresponding region of the 3615 bp EcoRI-KpnI fragment,
which was recovered from cosmid pHZ220 (Hu et al., 1994) and cloned into
EcoRI- and KpnI-digested pIJ2925. The recombinant 3615 bp fragment was
then excised as a BglII-BglII fragment and cloned into the unique BamHI site
of pHZ1358 (Sun et al., 2002) to create pJTU573, which was introduced into
strain FR-008 by conjugation from the nonmethylating E. coli donor strain
ET12567::pUZ8002 (Mazodier et al., 1989). ThioS colonies were counterse-
lected from the initial ThioR exconjugants after two rounds of nonselective
growth and used as mutant candidates tested by PCR with primer pairs P1
and P2, and ApoI digestion. The 1146 bp PCR product from the resultant
mutant (ZYJ-2) could be digested into 528 bp and 618 bp by ApoI. The PCR
fragment was also introduced into T vector (TaKaRa) for sequencing as further
confirmation of the desired mutation.
Point Mutation of DH18: ZYJ-3
To engineer the construction for introducing the mutation of H3084Y and
D3083V in the active motif of the DH18 domain (Figure 4A), 1475 and 1203 bp
fragments were amplified, respectively, with the primers: DH18P1, 50-GAC
ACGGAGTCCCCCGAGCCCCAGG-30 (sense); DH18P2, 50-CCG ACGGTGTA
CACGGCGAGCCAGG30 (antisense); and DH18P3, 50-CCTGGCTCGCCG
TGTACACCGTCGG-30 (sense); DH18P4, 50-CGCCCGAGAGCGGACCGAGG
AGTTG-30 (antisense) (the introduced restriction site [BsrGI] is underlined).
The two fragments were respectively cloned into transitional vectors (pBlue-
script II SK(+) and T-Vector) and sequenced, and then joined to a 2678 bp frag-
ment by the introduced BsrGI site. The 2678 bp fragment was then excised
and inserted into the BamHI site of pHZ1358 to generate plasmid pJTU572,
used as final construct for point mutation of DH18 by the same procedures
as that for the KR21 mutation. The desired mutation in the resultant mutant
strain (ZYJ-3) was tested by BsrGI digestion of the PCR product with primers
DH-test-L (50-GCTCTACCGTCCGCTTCGCC-30) and DH-test-R (50-CTGTGT
CCAGGTGGCGTCCG-30). The 706 bp PCR product amplified from themutantAll rights reserved
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Incomplete b-Ketone Processing and Polyenesshould be digested into 244 and 462 bp by BsrGI, and the PCR product was
sequenced as further proof of the desired mutation.
Double Mutations of KR21 and DH18: ZYJ-6
For obtaining double mutation of KR21 and DH18, pJTU572 was also trans-
ferred into the KR21 mutant (ZYJ-2) by conjugation with the same procedures
as that described above. The double mutation (ZYJ-6) was screened and con-
firmed by the same strategy as that used for ZYJ-2 and ZYJ-3.
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